MedPath

Effect of Acute Phenylcapsaicin Intake on Trained Cross-Training Athletes

Not Applicable
Active, not recruiting
Conditions
Performance
Registration Number
NCT06784271
Lead Sponsor
Universidad de Granada
Brief Summary

The aim of this study is to investigate the effect of acute phenylcapsaicin intake during a cross-training session on perceived exertion, performance, and recovery in cross-training athletes.

Detailed Description

Capsaicin appears to enhance athletic performance by reducing perceived effort, increasing mechanical performance (e.g., total volume load), and decreasing muscle damage. Given the close relationship between the metabolic and physiological responses of cross-training and supplementation with Phenylcapsaicin (PC), it could be expected that consuming capsaicin during cross-training would have a favorable impact on perceived effort, recovery, and performance.

25 women and 24 men trained in CrossFit consumed either Phenylcapsaicin (PC) or a placebo during a CrossFit class, which consisted of a 16-minute weightlifting segment and a 15-minute WOD. Both the Rating of Perceived Exertion (RPE) and the Perceived Recovery Status scale (RPS) were administered at the beginning of the session and at the end of each segment of the CrossFit session. DOMS was assessed using a visual analog scale at 24 and 48 hours after the CrossFit session.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Age: 18-35 years.
  • Body mass index: 18.5-30 kg/m2.
  • Ability to understand the instructions, objectives, and study protocol.
  • Minimum of 3 years of experience in crosstraining, with at least 6 hours of weekly training over the past 3 months.
  • Resident on the island of Tenerife.
Exclusion Criteria
  • History of a significant adverse cardiovascular event, renal insufficiency, cirrhosis, eating disorder, weight control surgical intervention, or type 2 diabetes mellitus.
  • Any chronic pathology in which the intake of nutritional supplements, especially pungent components, is not recommended.
  • Any condition that, in the investigator's judgment, would impair the ability to participate in the study or represent a personal risk to the participant.
  • Use of medications that may affect the study results.
  • Unstable body weight for 3 months prior to the start of the study (> 4 kg loss or gain in weight).
  • Active tobacco abuse or illicit drug use, or history of treatment for alcohol abuse.
  • On a special diet or prescribed for other reasons (e.g., celiac disease).

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Performance60min

Deep squat test at 70% of repetition maximum

Secondary Outcome Measures
NameTimeMethod
Heart rate60min

Heart rate will be measured with the Polar H10 heart rate monitor

Subjective fatigue throughe the RPE scale60min

Rate of perceived exertion scale

Recovery60min

Perceived Recovery Status Scale (RPS)

Delayed-onset muscle soreness (DOMS)60min

Delayed-onset muscle soreness (DOMS) scale (0-10 arbitrary units)

Capillar lactate levels60min

Capillar lactate levels

Performance: Weight used in the crosstraining session60min

Weight used in the crosstraining session

Performance: Time performed in the crosstraining session60min

Time performed in the crosstraining session

Trial Locations

Locations (1)

Universidad de la Laguna

🇪🇸

Tenerife, Spain

© Copyright 2025. All Rights Reserved by MedPath